Mostra risultati da 1 a 50 di 92
successivo >
Titolo Data di pubblicazione Autore(i) Rivista Editore
Neuroprotection by the Immunomodulatory Drug Pomalidomide in the Drosophila LRRK2WD40 Genetic Model of Parkinson’s Disease 2020 Casu, Maria Antonietta; Mocci, Ignazia; Isola, Raffaella; Pisanu, Augusta; Boi, Laura; Mulas, Gio...vanna; Greig, Nigel H.; Setzu, Maria Dolores; Carta, Anna R. FRONTIERS IN AGING NEUROSCIENCE
Can pioglitazone be potentially useful therapeutically in treating patients with covid-19? 2020 Carboni, E.; Carta, A. R.; Carboni, E. MEDICAL HYPOTHESES
Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: virus-based models versus inoculation of exogenous preformed toxic species 2020 Carta, A R; Boi, L; Pisanu, A; Palmas, M F; Carboni, E; De Simone, A JOURNAL OF NEUROSCIENCE METHODS
The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications 2020 Kuter, K. Z.; Cenci, M. A.; Carta, A. R. PROGRESS IN BRAIN RESEARCH
Nicotine, cocaine, amphetamine, morphine, and ethanol increase norepinephrine output in the bed nucleus of stria terminalis of freely moving rats 2019 Jadzic, Dragana; Bassareo, Valentina; Carta, Anna R; Carboni, Ezio ADDICTION BIOLOGY
Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model 2019 Di Benedetto, G.; Burgaletto, C.; Carta, A. R.; Saccone, S.; Lempereur, L.; Mulas, G.; Loreto, C....; Bernardini, R.; Cantarella, G. JOURNAL OF NEUROINFLAMMATION
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 2019 Boi, Laura; Pisanu, Augusta; Greig, Nigel; Scerba, Michael T; Tweedie, David; Mulas, Giovanna; Fe...nu, Sandro; Carboni, Ezio; Spiga, Saturnino; Carta, Anna R MOVEMENT DISORDERS
Trimethyl chitosan hydrogel nanoparticles for progesterone delivery in neurodegenerative disorders 2019 Lai, F.; Cardia, M. C.; Carta, A. R.; Caboni, P.; Maccioni, A. M.; Erbi, S.; Boi, L.; Meloni, M. ...C.; Sinico, C.; Lai, Francesco PHARMACEUTICS
Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease 2018 Lecca, Daniela; Janda, Elzbieta; Mulas, Giovanna; Diana, Andrea; Martino, Concetta; Angius, Fabri...zio; Spolitu, Stefano; Antonietta Casu, M; Simbula, Gabriella; Boi, Laura; Batetta, Barbara; Spiga, Saturnino; Carta, Annarosa BRITISH JOURNAL OF PHARMACOLOGY
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2018 Pisanu, Augusta; Boi, Laura; Mulas, Giovanna; Spiga, Saturnino; Fenu, Sandro; Carta, Anna R. JOURNAL OF NEURAL TRANSMISSION
Microglial phagocytosis and its regulation: A therapeutic target in parkinson’s disease? 2018 Janda, Elzbieta; Boi, Laura; Carta, Anna R. FRONTIERS IN MOLECULAR NEUROSCIENCE
Microglial phenotypes in Parkinson's disease and animal models of the disease 2017 Valerie, Joers; Malú, G. Tansey; Giovanna, Mulas; Annarosa Carta. PROGRESS IN NEUROBIOLOGY
L-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? 2017 Carta, Ar; Mulas, G; Bortolanza, M; Duarte, T; Pillai, E; Fisone, G; Vozari Raisman, R; Del Bel, E EJN. EUROPEAN JOURNAL OF NEUROSCIENCE
Role of Adenosine in the basal Ganglia 2017 Morelli, M.; Simola, N.; Popoli, P.; Carta, A.R. Elsevier
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 2016 Mulas, Giovanna; Espa, Elena; Fenu, Sandro; Spiga, Saturnino; Cossu, Giovanni; Pillai, Elisabetta...; Carboni, Ezio; Simbula, Gabriella; Jadžić, Dragana; Angius, Fabrizio; Spolitu, Stefano; Batetta, Barbara; Lecca, Daniela; Giuffrida, Andrea; Carta, Annarosa EXPERIMENTAL NEUROLOGY
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease 2015 Carta, A; Simuni, T EXPERT OPINION ON INVESTIGATIONAL DRUGS
Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice 2015 Lecca, Daniela; Nevin, Dk; Mulas, Giovanna; Casu, Ma; Diana, Andrea; Rossi, D; Sacchetti, G; Cart...a, Annarosa NEUROSCIENCE
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats 2015 Martinez, AA; Morgese, MG; Pisanu, A; Macheda, T; Paquette, MA; Seillier, A; Cassano, T; Carta, A...; Giuffrida, A NEUROBIOLOGY OF DISEASE
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2015 Mulas G, Elisabetta Pillai, Elena Espa, Sandro Fenu, Daniela Lecca, Saturnino Spiga, Anna R. C...arta
MPTP: advances from an evergreen neurotoxin 2014 Carta, Annarosa; Pisanu, Augusta; Barcia, C; Herrero, Mt Springer, New York, NY
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease 2014 Pisanu Augusta; Lecca Daniela; Mulas Giovanna; Wardas Jadwiga; Simbula Gabriella; Spiga Saturnino...; Carta Annarosa NEUROBIOLOGY OF DISEASE
Modulating microglia activity with PPAR-gamma agonists: a promising therapy for Parkinson's disease? 2013 Carta, A; Pisanu, A NEUROTOXICITY RESEARCH
PPAR-γ: Therapeutic Prospects in Parkinson's Disease. 2013 Carta A CURRENT DRUG TARGETS
SELECTIVE CHANGES IN DENDRITIC SPINES OF STRIATAL MEDIUM SPINY NEURONS IN A CHRONIC MOUSE MODEL OF PARKINSON'S DISEASE. 2013 Mura C; Mulas G; Piga A Podda R; Carta AR; Lecca D; Spiga S GISN
The MPTP/probenecid model of progressive Parkinson's disease. 2013 Carta, Annarosa; Carboni, Ezio; Spiga, Saturnino Humana Press - Springer
Role of prefrontal cortex dopamine and noradrenaline circuitry in addiction 2012 Carboni, Ezio; Cadeddu, Roberto; Carta, Annarosa InTech Web Org
The role of microglia–lymphocyte interaction in PD neuropathology 2012 Carta A BASAL GANGLIA
Dyskinesia in Parkinson's disease therapy 2012 Carta A; Giuffrida A; Fisone G. PARKINSON'S DISEASE
Nematicidal activity of 2-thiophenecarboxaldehyde and methylisothiocyanate from caper (Capparis spinosa) against Meloidogyne incognita 2012 Caboni, Pierluigi; Sarais, Giorgia; Aissani, Nadhem; Tocco, Graziella; Sasanelli, N; Liori, B; Ca...rta, Annarosa; Angioni, Alberto JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? 2011 Carta AR; Pisanu A; Carboni E PARKINSON'S DISEASE
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2011 CARTA AR; PISANU A; FRAU L; SPIGA S; CARBONI E International brain resesearch organization
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 2011 Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E. NEUROSCIENCE
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 2011 CARTA A; PISANU A; FRAU L; SPIGA S; CARBONI E SOC. NEUROSCI. ABSTR., 41TH ANNUAL MEETING SOCIETY FOR NEUROSCIENCE, WASHINGTON D.C., 12-16 NOVEMBRE 2011 Society for Neuroscience
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression 2010 Carta AR; Frau L; Pinna A; Morelli M. EXPERIMENTAL NEUROLOGY
Pathophysiological roles for purines: adenosine, caffeine and urate 2010 Morelli, Micaela; Carta, Annarosa; Kachroo, A; Schwarzschild, Ma PROGRESS IN BRAIN RESEARCH Björklund A, Cenci M.A.
Farmaci utilizzati nella terapia della Malattia di Parkinson e di altri disturbi motori 2010 CARTA A.R; PINNA A; CORSINI G.U; CARAMELLI A; MORELLI M Idelson-Gnocchi
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2010 CARTA A; FENU S; FRAU L; IBBA M; WARDAS J; CABONI P; CARBONI E SOCIETY FOR NEUROSCIENCE Society for Neurosciences
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 2010 Morelli M; Di Chiara G; Fenu S; Simola N; Carta AR
Farmaci antiparkinsoniani ed attivi in altri disturbi motori 2010 Carta, Annarosa; Pinna, Annalisa; Corsini, Giovanni Umberto; Caramelli, Andrea; Morelli, Micaela Idelson-Gnocchi
Adenosine signaling in the basal ganglia 2010 Morelli, Micaela; Simola, Nicola; Popoli, Patrizia; Carta, Annarosa Academic Press
Role of Adenosine in the Basal Ganglia 2010 Morelli, Micaela; Simola, Nicola; Popoli, P; Carta, Annarosa Elsevier B.V.
THE INTERRELATIONSHIP OF DOPAMINE AND NORADRENALINE IN THE PREFRONTAL CORTEX : FROM PHYSIOOLGY TO THERAPY 2009 Carboni, Ezio; Carta, Annarosa NOVA SCIENCE PUBLISHERS
Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease 2009 CARTA AR; KACHROO A; SCHINTU N; XU K; SCHWARZSCHILD MA; WARDAS J; MORELLI M JOURNAL OF NEUROCHEMISTRY
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 2009 SCHINTU N; FRAU L; IBBA M; CABONI P; GARAU A; CARBONI E; CARTA AR EUROPEAN JOURNAL OF NEUROSCIENCE
Adenosine A2A receptors and Parkinson's disease 2009 MORELLI M; CARTA AR; JENNER P HANDBOOK OF EXPERIMENTAL PHARMACOLOGY
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2009 SCHINTU N; FRAU L; IBBA M; GARAU A; CARBONI E; CARTA AR NEUROTOXICITY RESEARCH
Behavioural correlates of dopaminergic agonists dyskinetic potential in the 6-OHDA lesioned rat 2009 Carta, Annarosa; Frau, Lucia; Pinna, A; Morelli, Micaela Springer
Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress 2008 Carta AR; Casal Moreno C; Cadoni C; Tronci E; Di Chiara G. EUROPEAN JOURNAL OF NEUROSCIENCE
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 2008 FRAU L; SCHINTU N; CARBONI E; SILVAGNI A; CARTA AR
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence 2008 CARTA A; FRAU L; PONTIS S; PINNA A; MORELLI M PARKINSONISM & RELATED DISORDERS

Questionario e social

Condividi su: